中药穴位离子导入防治内镜逆行胰胆管造影术后高淀粉酶血症和胰腺炎临床研究

目的观察中药穴位外敷离子导入防治内镜逆行胰胆管造影(ERCP)术后高淀粉酶血症和胰腺炎的临床疗效。方法将300例ERCP术后患者随机分入治疗组和对照组,术后均给予常规治疗,治疗组加用中药穴位外敷离子导入。观察2组患者ERCP术后高淀粉酶血症和胰腺炎发生率及合并胰腺炎或胰高淀粉酶血症患者血清淀粉酶恢复至正常的天数,并对术后患者腹痛进行评分。结果剔除符合剔除标准的病例17例,治疗组纳入142例,对照组141例。治疗组术后高淀粉酶血症或胰腺炎的发生例数均少于对照组,但差异无统计学意义(P0.05);术后治疗组和对照组合并胰腺炎患者的淀粉酶恢复正常时间分别为(4.25±0.95)d和(5.28±1.11)d,差异无统计学意义(P0.05);术后治疗组和对照组合并胰高淀粉酶血症患者的淀粉酶恢复正常时间分别为(2.88±0.78)d和(3.81±1.62)d,2组比较差异有统计学意义(P0.05)。治疗组和对照组术后患者腹痛评分分别为(0.95±1.04)分和(1.21±1.12)分,2组比较差异有统计学意义(P0.05)。结论中药穴位外敷离子导入能促进ERCP术后合并高淀粉酶血症患者血清淀粉酶的恢复,并能较好地缓解术后腹痛症状。

Clinical Observation of Chinese Medicine Ion Introduction Through Acupiont in Preventing and Treating Hyperamylasemia and Pancreatitis Following Endoscopic Retrograde Cholangio eancreatography

Objective To observe the clinical effects of external application of Chinese medicine ion introduction through acupiont in the prevention and treatment of hyperamylasemia and pancreatitis following endoscopic retrograde cholangio pancreatography （ERCP）. Methods Three hundred subjects were divided into treatment group and control group randomly, and treated with routine therapy after surgery, moreover, treatment group was treated with external application of Chinese medicine ion introduction through acupiont. The incidence of hyperamylasemia and pancreatitis, the time of serum amylase returned to normal in patients with hyperamylasemia and pancreatitis was observed, and the abdominal pain after ERCP was scored. Results Excluding 17 cases according to the exclusion criteria, the treatment group included 142 cases and the control group included 141 cases. The hyperamylasemia and pancreatitis happened less frequently in the treatment group than in control group, but there was no significant difference （P 〉 0.05）. The time of serum amylase returned to normal in patients with pancreatitis was （4.25±0.95）d in treatment group and （5.28_＋ 1.11）d in control group, with no significant difference （P〉0.05）. The time of serum amylase returned to normal in patients with hyperamylasemia was （2.88±0.78）d in treatment group and （3.81 ± 1.62）d in control group, showed a significant difference （P〈0.05）. The score of abdominal pain was 0.95±1.04 in treatment group and 1.21±1.12 in control group, showed a significant difference （P〈0.05）. Conclusion External application of Chinese medicine ion introduction through acupoint can promote the recovery of the patients postoperative ERCP combined with hyperamylasemia or pancreatitis, and can better alleviate abdominal pain.